Venous thromboembolism in women taking hormonal contraceptives

@article{BlancoMolina2010VenousTI,
  title={Venous thromboembolism in women taking hormonal contraceptives},
  author={{\'A}. Blanco-Molina and M. Monreal},
  journal={Expert Review of Cardiovascular Therapy},
  year={2010},
  volume={8},
  pages={211 - 215}
}
  • Á. Blanco-Molina, M. Monreal
  • Published 2010
  • Medicine
  • Expert Review of Cardiovascular Therapy
  • Hormonal contraceptives are a popular method of contraception, but their use has been associated with an increased risk for venous thromboembolism. In order to reduce such risk, these compounds have been changed in their dosage, chemical composition and route of administration. The absolute risk of death from pulmonary embolism in contraceptive users has been estimated to be 10.5 (95% CI: 6.2–16.6) per million woman-years. The safest option is an oral contraceptive containing levonorgestrel… CONTINUE READING
    35 Citations
    Hormonal Contraception and the Informed Consent*
    • 1
    [Cardiovascular risks of combined oral contraceptives - beyond the French controversy].
    • 8
    Pulmonary embolism and deep vein thrombosis in a woman taking contraceptives and with unhealthy life habit: a case report.
    • Zhi Wang, J. Huang
    • Medicine
    • Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
    • 2013
    Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study
    • 15
    • PDF
    Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
    • 57
    The effects of hormonal contraceptives on female sexuality: a review.
    • 150
    • PDF
    Significant Risks of Oral Contraceptives (OCPs)
    • 10
    Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
    • 13
    • PDF

    References

    SHOWING 1-10 OF 35 REFERENCES
    Venous thromboembolism during pregnancy, postpartum or during contraceptive use.
    • 66
    • PDF
    Hormone therapy and thromboembolic disease
    • 36